FOXP3 and autoimmune disease: Quantitation of the impact of Tregs on tumor growth has been difficult in the past due to the fact that mice lacking Tregs die within 3-4 weeks of birth and methods to systemically deplete FOXP3+ cells from mature mice have led to serious autoimmune disorders (40–42).